63E-15777-16996
4 vaccinations
2 coded responses
46 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 601 / IL
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Registered in v-safe
-
2021-01-29
Dose 1 — Pfizer-BioNTech
- 2021-01-29
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
-
2021-02-19
Dose 2 — Pfizer-BioNTech
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-04-02
- 2021-05-21
- 2021-08-22
-
2021-09-27
Dose 3 — Pfizer-BioNTech
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-12-27
-
2022-03-30
Survey response — 6 months, dose 3MedDRA: Office visit, Uterine mass — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Uterine mass expected to be cyst or polyp. D&C scheduled. · Healthcare visit (other): Gyne appointmentMedDRA releases: 2024-11 · check-in free text available
-
2022-03-30
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-31
-
2022-04-27
Dose 4 — Pfizer-BioNTech
- 2022-04-28
- 2022-04-29
- 2022-04-30
- 2022-05-02
- 2022-05-04
- 2022-05-13
- 2022-05-18
-
2022-05-25
Survey response — day 28, dose 4MedDRA: Chills, Fatigue, Pain, Pyrexia — Feeling: GoodFree text: Chills/fever Fatigue Body achesMedDRA releases: 2024-11 · check-in free text available
- 2022-06-03
- 2022-06-08
- 2022-07-27
- 2022-10-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
| 4 | 2022-04-27 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-30 | Unsuccessful |
Free text
Release 11 — 6 months, dose 3
Symptoms: Uterine mass expected to be cyst or polyp. D&C scheduled.
Healthcare visit (other): Gyne appointment
Release 11 — day 28, dose 4
Symptoms: Chills/fever Fatigue Body aches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Uterine mass | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release